DNM1L and diabetic retinopathy: Our previous report [10] as well as studies from other investigators [29,53,54] support our current finding that reducing Drp1 overexpression could be beneficial against diabetes-induced apoptosis in retinal vascular cells, and that targeting Drp1 overexpression could be a useful strategy against the development of retinal vascular lesions associated with diabetic retinopathy.